[EN] THERAPEUTICALLY ACTIVE FUSED PYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIMIDINE FUSIONNÉS À ACTIVITÉ THÉRAPEUTIQUE
申请人:UCB PHARMA SA
公开号:WO2013024291A3
公开(公告)日:2013-04-18
THERAPEUTICALLY ACTIVE FUSED PYRIMIDINE DERIVATIVES
申请人:UCB Biopharma SPRL
公开号:EP2744812B1
公开(公告)日:2016-07-20
US9227984B2
申请人:——
公开号:US9227984B2
公开(公告)日:2016-01-05
Therapeutically Active Fused Pyrimidine Derivatives
申请人:Brookings Daniel Christopher
公开号:US20140309222A1
公开(公告)日:2014-10-16
A series of monocyclic or bicyclic diamine-substituted thieno[2,3-d]pyrimidine and isothiazolo[5,4-d]pyrimidine derivatives are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.